the role of fedratinib in myelofibrosis
Published 4 years ago • 296 plays • Length 7:43Download video MP4
Download video MP3
Similar videos
-
1:16
dr. mesa on the fda approval of fedratinib in myelofibrosis
-
1:29
dr. mesa on the fda approval of fedratinib in myelofibrosis
-
1:00
dr. mesa on the utility of ruxolitinib versus fedratinib in myelofibrosis
-
1:24
dr. mesa on current data with ruxolitinib and fedratinib in myelofibrosis
-
1:11
dr. mesa on the utility of fedratinib for patients with myelofibrosis who progress on ruxolitinib
-
1:31
dr. kuykendall on toxicity profiles of ruxolitinib and fedratinib in myelofibrosis
-
1:42
dr. mesa on ruxolitinib vs fedratinib in myelofibrosis treatment
-
5:10
fedratinib in mf: jakarta2 and freedom trials
-
2:07
fedratinib for myelofibrosis
-
1:12
dr. mesa on the differences between fedratinib and ruxolitinib in myelofibrosis
-
1:27
dr. kuykendall on choosing ruxolitinib or fedratinib in myelofibrosis
-
1:06
fedratinib: mpn-associated myelofibrosis
-
4:46
fedratinib for primary myelofibrosis
-
1:27
jakarta and jakarta2: os and pfs analysis of fedratinib in myelofibrosis
-
6:08
ruxolitinib’s role in treating myelofibrosis
-
0:50
dr. snyder on how ruxolitinib and fedratinib may pave the way to transplant in myelofibrosis
-
1:14
dr. mesa on the emergence of jak inhibitors in myelofibrosis
-
1:07
dr. garcia on the role of navitoclax in myelofibrosis
-
3:09
key data for the use of fedratinib in mf